WST Stock News & Catalysts – West Pharmaceutical Services

FEATURED

West to Participate in Upcoming Investor Conference

EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies

Summary

Nov 4, 2026, 6:00 AM ·PRNewswire

RECENT

West Reports Third-Quarter 2026 Results

Raising Full-Year Net Sales and Adjusted-Diluted EPS guidanceEXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a leading provider of innovative, high-quality injectable solutions

Oct 29, 2026, 6:00 AM ·PRNewswire

West Declares Quarterly Dividend

EXTON, Pa., Oct. 19, 2026 /PRNewswire/ -- On October 19, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration,

Oct 19, 2026, 6:04 PM ·PRNewswire

West to Host Third-Quarter 2026 Conference Call

EXTON, Pa., Oct. 8, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter

Oct 8, 2026, 6:00 AM ·PRNewswire

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in

Oct 5, 2026, 6:00 AM ·PRNewswire

West to Participate in Upcoming Investor Conferences

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following

Aug 26, 2026, 4:00 PM ·PRNewswire

West Declares Quarterly Dividend

EXTON, Pa., July 21, 2026 /PRNewswire/ -- On July 21, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, declared

Jul 21, 2026, 4:00 PM ·PRNewswire

West to Host Second-Quarter 2026 Conference Call

EXTON, Pa., July 7, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter

Jul 7, 2026, 6:00 AM ·PRNewswire

West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System

EXTON, Pa., July 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced the company completed the sale and

Jul 1, 2026, 4:30 PM ·PRNewswire

West Appoints Michel Lagarde to be President and Chief Executive Officer

Experienced healthcare and life sciences executive to lead the Company's next phase of growth and innovationEXTON, Pa., June 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in

Jun 1, 2026, 4:30 PM ·PRNewswire

West to Participate in Upcoming Investor Conferences

EXTON, Pa., April 28, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following

Apr 28, 2026, 6:00 AM ·PRNewswire

West Reports First-Quarter 2026 Results

Strong Start to the Year and Raising Full-Year Revenue and EPS guidanceEXTON, Pa., April 23, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable

Apr 23, 2026, 6:00 AM ·PRNewswire

West to Host First-Quarter 2026 Conference Call

EXTON, Pa., April 9, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2026

Apr 9, 2026, 6:00 AM ·PRNewswire

West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity

EXTON, Pa., March 31, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a global leader in innovative solutions for injectable drug administration, announced today the opening of its new building at its

Mar 31, 2026, 11:46 AM ·PRNewswire

Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.

EXTON, Pa., March 9, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST) announced today that Eric M. Green has informed the Board of Directors that he plans to retire from his positions as President,

Mar 9, 2026, 4:30 PM ·PRNewswire

West Pharmaceutical Services, Inc. WST · News